AMGN

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know